More specifically, 37.5% of the myasthenic patients with anti-striational antibodies (anti-titin, anti-ryanodine, and anti-Kv 1.4) develop myocarditis, which manifests as cardiac failure and/or arrythmias at 13 to 211 months from MG onset [33]. The gene discussed is TTN; the disease is myasthenia gravis.